Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components-Reference-Cited by-同舟云学术

Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components

Published:2023-12-27 Issue:1 Volume:166 Page:79-87
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Bennebroek Carlien A.^ORCID,Schouten Christiaan R.,Montauban-van Swijndregt Maartje C.,Saeed Peerooz,Porro Giorgio L.,Pott Jan W. R.,Dittrich Anne T. M.,Oostenbrink Rianne,Schouten-van Meeteren Antoinette Y.,de Jong Marcus C.,de Graaf Pim

Funder

ODAS Stichting

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-023-04516-y.pdf

Reference20 articles.

1. Falzon K, Drimtzias E, Picton S, Simmons I (2018) Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) low-grade glioma 2004 trial UK cohort. Br J Ophthalmol 102(10):1367–1371. https://doi.org/10.1136/bjophthalmol-2017-311305

2. Gil Margolis M, Yackobovitz-Gavan M, Toledano H, Tenenbaum A, Cohen R, Phillip M, Shalitin S (2023) Optic pathway glioma and endocrine disorders in patients with and without NF1. Pediatr Res 93:233–241. https://doi.org/10.1038/s41390-022-02098-5

3. Santoro C, Perrotta S, Picariello S, Scilipoti M, Cirillo M, Quaglietta L, Cinalli G, Cioffi D, Di Iorgi N, Maghnie M, Gallizia A, Parpagnoli M, Messa F, De Sanctis L, Vannelli S, Marzuillo P, Miraglia Del Giudice E, Grandone A (2020) Pretreatment endocrine disorders due to optic pathway gliomas in pediatric neurofibromatosis type 1: multicenter study. J Clin Endocrinol Metab 105:e2214–e2221. https://doi.org/10.1210/clinem/dgaa138

4. Opocher E, Kremer LC, Da Dalt L, van de Wetering MD, Viscardi E, Caron HN, Perilongo G (2006) Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 42:1807–1816. https://doi.org/10.1016/j.ejca.2006.02.022

5. Hawkins C, Walker E, Mohamed N, Zhang C, Jacob K, Shirinian M, Alon N, Kahn D, Fried I, Scheinemann K, Tsangaris E, Dirks P, Tressler R, Bouffet E, Jabado N, Tabori U (2011) BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma. Clin Cancer Res 17:4790–4798. https://doi.org/10.1158/1078-0432.Ccr-11-0034